Neuraxis revenue was $3.22M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q2 2025) ending on Jun 30, 2025 was $894.1k, down 0.2% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, NRXS annual revenue was $2.7M, with 9.2% growth year-over-year.
NRXS past revenue growth
How has NRXS's revenue growth performed historically?
On Invalid Date, Neuraxis (NYSEMKT: NRXS) reported Q2 2025 revenue of $894.09 thousand up 46.21% year over year. In the same quarter last year, Neuraxis's revenue was $611.50 thousand.
What was Neuraxis's revenue in 2024?
Neuraxis's annual revenue for the twelve months ending Dec 31, 2024 was $2.69 million, a 9.18% increase year over year.
How much does Neuraxis make in a day?
Based on Neuraxis annual revenue for the past four years, NRXS makes an average of $7,227.39 per day.
What was Neuraxis's annual revenue growth in the past year?
As of Q3 2025, Neuraxis's revenue has grown 41.93% year over year. This is 109.97 percentage points lower than the US Biotechnology industry revenue growth rate of 151.9%. Neuraxis's revenue in the past year totaled $3.22 million.
How much does Neuraxis make in a year?
Neuraxis's revenue by year for the past four years is:
Neuraxis's revenue for the twelve months ending Dec 31, 2024 was $2.69 million, a 9.18% increase year over year.
Neuraxis's annual revenue for Dec 31, 2023 was $2.46 million, a 8.37% decrease from 2022.
Neuraxis's annual revenue for 2022 was $2.68 million, a 1.34% decrease from 2021.
Neuraxis's annual revenue for 2021 was $2.72 million, a 24.82% increase from 2020.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.